401 related articles for article (PubMed ID: 28401358)
1. mRNA Cancer Vaccines-Messages that Prevail.
Grunwitz C; Kranz LM
Curr Top Microbiol Immunol; 2017; 405():145-164. PubMed ID: 28401358
[TBL] [Abstract][Full Text] [Related]
2. mRNA Cancer Vaccines.
Fiedler K; Lazzaro S; Lutz J; Rauch S; Heidenreich R
Recent Results Cancer Res; 2016; 209():61-85. PubMed ID: 28101688
[TBL] [Abstract][Full Text] [Related]
3. Challenges and advances towards the rational design of mRNA vaccines.
Pollard C; De Koker S; Saelens X; Vanham G; Grooten J
Trends Mol Med; 2013 Dec; 19(12):705-13. PubMed ID: 24138818
[TBL] [Abstract][Full Text] [Related]
4. Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studies.
Diken M; Kreiter S; Selmi A; Türeci O; Sahin U
Methods Mol Biol; 2013; 969():235-46. PubMed ID: 23296938
[TBL] [Abstract][Full Text] [Related]
5. Tumor vaccination using messenger RNA: prospects of a future therapy.
Kreiter S; Diken M; Selmi A; Türeci Ö; Sahin U
Curr Opin Immunol; 2011 Jun; 23(3):399-406. PubMed ID: 21497074
[TBL] [Abstract][Full Text] [Related]
6. Programming human dendritic cells with mRNA.
Lee J; Boczkowski D; Nair S
Methods Mol Biol; 2013; 969():111-25. PubMed ID: 23296931
[TBL] [Abstract][Full Text] [Related]
7. mRNA-based dendritic cell vaccines.
Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
[TBL] [Abstract][Full Text] [Related]
8. mRNA therapeutics in cancer immunotherapy.
Beck JD; Reidenbach D; Salomon N; Sahin U; Türeci Ö; Vormehr M; Kranz LM
Mol Cancer; 2021 Apr; 20(1):69. PubMed ID: 33858437
[TBL] [Abstract][Full Text] [Related]
9. Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination.
Michiels A; Tuyaerts S; Bonehill A; Heirman C; Corthals J; Thielemans K
Methods Mol Biol; 2008; 423():155-63. PubMed ID: 18370196
[TBL] [Abstract][Full Text] [Related]
10. RNA-Based Vaccines in Cancer Immunotherapy.
McNamara MA; Nair SK; Holl EK
J Immunol Res; 2015; 2015():794528. PubMed ID: 26665011
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination.
Sun X; Zeng L; Huang Y
J Gene Med; 2019 Jul; 21(7):e3089. PubMed ID: 30958606
[TBL] [Abstract][Full Text] [Related]
12. Improving Dendritic Cell Cancer Vaccine Potency Using RNA Interference.
Sæbøe-Larssen S; Sioud M
Methods Mol Biol; 2020; 2115():249-258. PubMed ID: 32006405
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients.
Lesterhuis WJ; De Vries IJ; Schreibelt G; Schuurhuis DH; Aarntzen EH; De Boer A; Scharenborg NM; Van De Rakt M; Hesselink EJ; Figdor CG; Adema GJ; Punt CJ
Anticancer Res; 2010 Dec; 30(12):5091-7. PubMed ID: 21187495
[TBL] [Abstract][Full Text] [Related]
14. The ReNAissanCe of mRNA-based cancer therapy.
Van Lint S; Renmans D; Broos K; Dewitte H; Lentacker I; Heirman C; Breckpot K; Thielemans K
Expert Rev Vaccines; 2015 Feb; 14(2):235-51. PubMed ID: 25263094
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunological effects of mRNA vaccines in malignant diseases.
Heine A; Juranek S; Brossart P
Mol Cancer; 2021 Mar; 20(1):52. PubMed ID: 33722265
[TBL] [Abstract][Full Text] [Related]
16. mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.
Van Lint S; Heirman C; Thielemans K; Breckpot K
Hum Vaccin Immunother; 2013 Feb; 9(2):265-74. PubMed ID: 23291946
[TBL] [Abstract][Full Text] [Related]
17. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
[TBL] [Abstract][Full Text] [Related]
18. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
Li J; Sun Y; Jia T; Zhang R; Zhang K; Wang L
Int J Cancer; 2014 Apr; 134(7):1683-94. PubMed ID: 24105486
[TBL] [Abstract][Full Text] [Related]
19. Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
Copur M
Oncology (Williston Park); 2021 Apr; 35(4):190-198. PubMed ID: 33893760
[TBL] [Abstract][Full Text] [Related]
20. Nonlysosomal Route of mRNA Delivery and Combining with Epigenetic Regulation Optimized Antitumor Immunoprophylactic Efficacy.
Liu Y; Liu X; Huang J; Shi Y; Luo Z; Zhang J; Guo X; Jiang M; Li X; Yin H; Qin B; Guan G; Luo L; Zhou Y; You J
Adv Healthc Mater; 2023 Feb; 12(4):e2202460. PubMed ID: 36366890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
